¾ÅÖÝÓ°Ôº

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Key aspects of modern drug discovery

17 - 18 October 2019, Nottingham, United Kingdom


Introduction
Designed and delivered by experts from industry and academia, this training event will provide a comprehensive overview of the pre-clinical drug discovery process. The workshop will focus on small molecule target identification and validation, hit-to-lead and lead optimisation, as well as on pre-clinical drug development and toxicology.
The programme will include lectures, case studies and group discussions, providing great networking opportunities and encouraging collaboration among delegates and speakers. The event is suitable for recent graduates, PhD students and early career scientists interested in working in the pre-clinical drug discovery industry.

Programme coordinators:

Rick Davies, AstraZeneca
Jacqui Piner, GSK
John Unitt, Sygnature Discovery
Heather Wallace, University of Aberdeen
John Ladbury, University of Leeds
John Colyer, University of Leeds

The event is sponsored by the ¾ÅÖÝÓ°Ôº, and it is supported by the Royal Society of Biology and the British Pharmacological Society.
Sponsorship & supporting organisations
Venue
BioCity Nottingham

BioCity Nottingham, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, United Kingdom

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*